PRESS RELEASES

PRESS RELEASES

Date Title and Summary Additional Formats
Toggle Summary Monthly information related to total number of voting rights and shares composing the share capital – August 31, 2020
LYON, France, Sept. 14, 2020 (GLOBE NEWSWIRE) -- Article 223-16 of general regulation of French Autorité des Marchés Financiers Lyon – France Listing markets: Euronext Paris from Euronext (Market segment C -  ISIN Code: FR0011471135- Symbol: ERYP) & Nasdaq Global Select Market in the United-States
View HTML
Toggle Summary Monthly information related to total number of voting rights and shares composing the share capital – December 31, 2020
                                                                                    Monthly information related to total number of voting rights and shares composing the share capital – December 31, 2020. Article 223-16 of general regulation of French Autorité des Marchés Financiers Lyon – France
Toggle Summary Report - Erytech’s Combined Shareholders’ Meeting on June 25, 2021
        REPO R T - ERYTECH’S COMBINED SHAREHOLDERS’ MEE TING ON JUNE 25, 2021 SS RELEASE          Lyon (France), June 2 5 , 2021 – ERYTECH Pharma (Euronext: ERYP - Nasdaq: ERYP) announced that its 202 1 Annual General Meeting was held in Lyon on Friday, June 25 , 2021 .
View HTML
Toggle Summary Avenant au Contrat de Liquidité
ERYTECH : Avenant au Contrat de Liquidité March 26, 2014 03:00 AM Eastern Daylight Time LYON, France--( BUSINESS WIRE )--Regulatory News: ERYTECH (Paris:ERYP) (Euronext Paris : FR0011471135 - ERYP), société biopharmaceutique française qui conçoit des traitements innovants contre les leucémies
View HTML
Toggle Summary Bilan semestriel du contrat de liquidité confié à la société de bourse Bryan, Garnier & Co.
ERYTECH Pharma : Bilan semestriel du contrat de liquidité confié à la société de bourse Bryan, Garnier & Co. July 02, 2014 12:00 PM Eastern Daylight Time LYON, France--( BUSINESS WIRE )--Regulatory News: ERYTECH Pharma (Paris:ERYP) (Euronext Paris : FR0011471135 - ERYP), société biopharmaceutique
View HTML
Toggle Summary CORRECTING and REPLACING: Erytech Pharma: Information Related to Total Number of Voting Rights and Shares Composing the Share Capital
December 2015 Article 223-16 of general regulation of French Autorité des Marchés Financiers LYON, France --(BUSINESS WIRE)--Feb. 4, 2016-- Regulatory News: This replaces the announcement made at 2:20 pm on January 12 due to the following corrections: The total of brut voting rights of 9 625 437 is
View HTML
Toggle Summary ERYTECH : ASSEMBLEE GENERALE MIXTE DU 17 JUIN 2014
ERYTECH : ASSEMBLEE GENERALE MIXTE DU 17 JUIN 2014 Modalités de mise à disposition des documents préparatoires May 27, 2014 03:48 PM Eastern Daylight Time LYON, France--( BUSINESS WIRE )--Regulatory News : ERYTECH Pharma (Paris:ERYP) (Euronext Paris : FR0011471135 - ERYP), la société
View HTML
Toggle Summary Erytech : Information Related to Total Number of Voting Rights and Shares Composing the Share Capital - August 2016
Article 223-16 of general regulation of French Autorité des Marchés Financiers LYON, France --(BUSINESS WIRE)--Sep. 1, 2016-- Regulatory News : Erytech (Paris:ERYP) (ADR:EYRYY): Date   Total of shares composing the share capital   Total of brut (1) voting rights   Total of net (2) voting rights 31
View HTML
Toggle Summary ERYTECH : rapport d’activité et résultats financiers du 1er semestre 2013
ERYTECH : rapport d’activité et résultats financiers du 1 er semestre 2013 Solides performances opérationnelles et bonne progression des programmes cliniques Niveau de trésorerie élevé suite au succès de l’introduction en bourse et gestion rigoureuse des dépenses Solide news flow à
View HTML
Toggle Summary ERYTECH : Monthly Information Related to Total Number of Voting Rights and Shares Composing the Share Capital –February 28, 2018
Article 223-16 of general regulation of French Autorité des Marchés Financiers LYON, France --(BUSINESS WIRE)--Mar. 7, 2018-- Regulatory News : ERYTECH (Euronext: ERYP- Nasdaq: ERYP) Listing markets: Euronext Paris from Euronext (Market segment B - ISIN Code: FR0011471135- Symbol : ERYP) & Nasdaq
View HTML
Top